INBI Matei Bals

What INBI Matei Bals does

INBI Matei Bals (Institutul Național de Boli Infecțioase Prof. Dr. Matei Balș) is Romania's national reference center for infectious diseases, operating as a public medical institution under the Ministry of Health since its establishment as a national institute in July 2007, with institutional roots dating to 1880. The institute operates a 690-bed facility at Str. Dr. Calistrat Grozovici Nr. 1, Sector 2, Bucharest, comprising 13 clinical sections (6 adult infectious disease, 4 pediatric infectious disease including 2 HIV/AIDS-specialized units, 2 ICUs, and day hospitalization units), 7 specialized laboratories (biochemistry, molecular genetics, hematology, immunology, microbiology, virology-serology, radiology-imaging), a 24-hour specialized emergency department (CPU-S), an endoscopy unit, blood transfusion unit, and palliative care center under development. Technology infrastructure includes an integrated Hospital Information System spanning all laboratory, clinical, pharmacy, accounting, and administrative functions (450 computers), advanced life-support equipment (artificial lung, liver, kidney support), molecular diagnostic capabilities, and the internally developed Carmelli Score validated by ANMCS. The institute holds ISO 9001:2000 certification — the first Romanian public health unit to do so — and SRAC/IQNet accreditation.

The institute serves as Romania's frontline institution for pandemic and epidemic response, having been the only Romanian unit involved in managing SARS, pandemic influenza, Ebola, and COVID-19 cases. It houses the Romanian National HIV/AIDS Program, the Compartment for Monitoring and Evaluating HIV/AIDS Infection in Romania, and the Academia HIV/SIDA (est. 2009). The institute is also a teaching hospital affiliated with UMF Carol Davila, having trained over 10,000 students and 200+ medical residents annually. International collaborations include the European Centre for Disease Prevention and Control (ECDC), WHO, the Norwegian Institute of Public Health (AMR project), and EU-JAMRAI 2.

Revenue derives from contracts with Casa Națională de Asigurări de Sănătate (CNAS) and the Casa de Asigurări de Sănătate a Municipiului București for CNAS-reimbursed services (continuous hospitalization, day hospitalization, outpatient), supplemented by EU grant funding through POIM, POCU, EEA Financial Mechanism, PNRR, and direct Ministry of Health allocations. Active EU-funded projects include COVID19-CARE (46.5M lei), HepTest (19.8M lei), POCU (12.4M lei), Palliative Care Center (12.7M lei), and the AMR project (1.74M EUR). Patient services are publicly subsidized under Romania's national health insurance system, with a published price list for medical analyses and triage-based emergency access.

Name

INBI Matei Bals

Legal name

Institutul Național de Boli Infecțioase Prof. Dr. Matei Balș

Website

https://mateibals.ro

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

INBI Matei Bals is Romania's national reference center for infectious diseases — a 690-bed public teaching hospital in Bucharest providing specialized diagnosis, treatment, HIV/AIDS program management, pandemic response, and laboratory diagnostics under the Ministry of Health.

Ownership category

akta.pro rank

Product category

Infectious Disease Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical and Diagnostic Laboratories (6215)

SIC

Services-Hospitals (8060), Services-Medical Laboratories (8071)

akta.pro primary industry

Inpatient Infectious Disease & Isolation Specialty Hospitals (HLAFAHAI)

akta.pro secondary industries

Hospital Epidemiology & Infection Prevention (HLAKAGAF), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

Keywords

• Infectious disease hospital
• National reference center
• HIV/AIDS treatment
• Public healthcare services
• Medical laboratory diagnostics

Headquarters

HQ city

București

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. National Health Insurance (CNAS) Contracts: As a public healthcare institution under Romania's national health system, the institute generates revenue through contracted services with Casa Nationala de Asigurari de Sanatate (CNAS) and Casa de Asigurari de Sanatate a Municipiului Bucuresti. Services are provided to insured patients under public health insurance coverage including continuous hospitalization, day hospitalization, and outpatient services.

Pricing tiers

Distribution channels5 records

Marketing channels5 records

Core offering

INBI Matei Bals is Romania's national reference center for infectious diseases, operating a 690-bed hospital facility that delivers comprehensive diagnosis, treatment, and monitoring of infectious diseases for adult and pediatric patients. The institute provides integrated medical services through 13 clinical sections (including 6 adult, 4 pediatric, 2 ICUs, and day hospitalization units), specialized departments (HIV/AIDS, emergency, endoscopy, endocrinology), and 7 diagnostic laboratories, complemented by applied research and medical training programs.

Product overview

INBI Matei Bals is a national infectious disease institute offering a comprehensive healthcare portfolio centered on its 690-bed hospital facility. The institution provides integrated medical services through 13 clinical sections (6 adult, 4 pediatric, 2 intensive care), multiple specialized departments (Emergency, HIV/AIDS Center, Endoscopy, Endocrinology), and 7 laboratories (Biochemistry, Molecular Genetics, Hematology, Immunology, Microbiology, Virology, Radiology). The institute operates as a unified platform combining inpatient care, day hospitalization, emergency services, laboratory diagnostics, and applied research under one organization, with satellite palliative care centers under development through PNRR funding.

Differentiator

Problem solved

Functional benefit

Brands

• Centrul Român HIV/SIDA: National coordination center for HIV/AIDS monitoring and treatment in Romania, serving as liaison between governmental and non-governmental institutions.
• Academia HIV/SIDA

Products and services

• Infectious Disease Healthcare Services

Quantifiable outcome

• Successfully managed 6 Ebola alarms, responding to pandemic/epidemic threats including SARS, pandemic influenza, and COVID-19 with rapid patient evacuation and containment
• +5 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and major.

• Ministerul Investitiilor si Proiectelor Europene (MIPE) / Programul SanatatecoreStrategic or Co-development Partner · 28 January 2026MIPE serves as the Managing Authority for the Health Program (Programul Sanatate) through which EU funding is channeled. INBI Matei Bals receives EU funding through multiple projects including HepTest (contract DGPS 10944/28.01.2026) and palliative care center project (contract 154192/22.12.2025). MIPE provides both funding authorization and oversight.
• Spitalul Judetean de Urgenta Miercurea CiuccoreStrategic or Co-development Partner · 28 January 2026INBI Matei Bals implements the HepTest hepatitis screening project as the beneficiary in partnership with Spitalul Judetean de Urgenta Miercurea Ciuc as a partner. The project targets 18,751 vulnerable persons in the Central Region over 48 months.
• Institutul de Sanatate Publica din Norvegia (Norwegian Institute of Public Health)coreStrategic or Co-development Partner · 30 July 2020Norwegian Institute of Public Health is the partner institution in the AMR (Antimicrobial Resistance) project funded by EEA Financial Mechanism 2014-2021 (budget: 1,741,154 euro). The project focuses on strengthening institutional capacity for control of healthcare-associated infections and antibiotic consumption management. The partnership included study visits for Romanian doctors to Norwegian hospitals and WHO technical expertise.
• Ministerul Sanatatii din RomaniacoreStrategic or Co-development Partner · 30 July 2020The Ministry of Health serves as the Program Operator for the EEA Financial Mechanism project and the Health Program. It coordinates national health policy including AMR/IAAM strategies. INBI developed the National Strategic Framework and National Action Plan for AMR and IAAM under this partnership.
• Organizatia Mondiala a Sanatatii (WHO)majorStrategic or Co-development Partner · 30 July 2020WHO provides technical expertise support to the AMR project implemented by INBI Matei Bals. WHO representatives participated in project launch conferences. The institute aligns its AMR strategy with WHO guidelines and European recommendations.
• Asociatia PartNET - Parteneriat pentru dezvoltare durabilamajorStrategic or Co-development Partner · 11 December 2017PartNET is the implementing partner in the POCU project (cod SMIS 108129) 'Competence and Quality in Priority Medical Services' (12,385,993.88 lei). The project ran from December 2017 to December 2020 and trained 940 healthcare professionals across Romania.
• European Center for Disease Prevention and Control (ECDC)majorStrategic or Co-development PartnerThe institute maintains multiple international collaborations with ECDC being described as the most significant. ECDC provides epidemiological support, best practice guidelines, and European infectious disease surveillance coordination.
• Universitatea de Medicina si Farmacie 'Carol Davila' BucurestimajorStrategic or Co-development PartnerUMF Carol Davila is the affiliated teaching institution providing clinical teaching integration. The institute serves as a teaching hospital with integrated clinical instruction for medical students and residents, having trained over 10,000 students and 200+ residents annually.
• Pilot Hospitals Network (AMR Project)coreStrategic or Co-development PartnerFive Romanian pilot hospitals participate in the AMR project under INBI Matei Bals leadership: Spitalul Universitar de Urgenta Elias, Spitalul Universitar de Urgenta Militar Central 'Dr. Carol Davila', Spitalul Judetean de Urgenta Bacau, Spitalul Clinic Judetean de Urgenta Cluj-Napoca, and Spitalul Clinic Judetean de Urgenta Targu Mures.
• EU-JAMRAI 2 (European Joint Action on Antimicrobial Resistance)majorStrategic or Co-development PartnerINBI participates in EU-JAMRAI 2, a European Joint Action on Antimicrobial Resistance and Healthcare Associated Infections 2. The institute is hiring project staff (Coordonator activitati WPs) through August 2025 to December 2027.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Karolinska University Hospital - Infectious Diseases Department: Sweden's premier university hospital with a major infectious diseases department providing specialty inpatient ID care, HIV/AIDS programs, and research. Comparable in combining high-acuity specialty care with academic/teaching hospital role.
• Bernhard Nocht Institute for Tropical Medicine: Germany's national reference center for tropical and infectious diseases, providing inpatient care plus research and surveillance. Comparable in combining a specialty hospital with national reference laboratory functions and international outbreak response.
• Hospital Clinic de Barcelona - Infectious Diseases Unit: Major Spanish university hospital with a leading infectious diseases department providing inpatient ID care, HIV/AIDS treatment, tropical medicine, and international health. Comparable as a tertiary specialty ID unit embedded in a large teaching hospital.
• Institutul National de Cercetare-Dezvoltare Cantacuzino: Romania's other national infectious disease and immunology research institute. Operates as a state entity under the same Ministry with overlapping mission areas in vaccines, infectious disease surveillance, and biological reference functions.
• National Centre for Infectious Diseases (Singapore): Singapore's national specialty hospital for infectious diseases providing inpatient care, HIV/STI management, outbreak response, and public health functions in a single integrated institution. Directly comparable as a national ID specialty center with pandemic response mandate.
• Spitalul Clinic de Boli Infectioase si Tropicale Dr. Victor Babes: Another major Romanian infectious and tropical diseases hospital in Bucharest. Directly comparable as a state-run specialty ID hospital competing for the same patient population, talent pool, and government contracts within Romania's capital.
• Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani: Rome-based Italian national institute for infectious diseases and isolation hospitals, directly comparable as a national specialty hospital providing inpatient infectious disease care, HIV/AIDS programs, and pandemic response. Similar scale, mission, and integration of clinical care, research, and public health functions.
• Universitätsspital Basel - Infektiologie & Spitalhygiene: Swiss university hospital with a strong infectious diseases and hospital epidemiology service combining inpatient ID care with infection prevention programs (analogous to Matei Bals' SPIAAM). Comparable as a teaching hospital integrating specialty ID care with AMR and infection control leadership.

Broad incumbents

• Robert Koch Institute: Germany's federal government agency for disease surveillance, prevention, and infectious disease control. Comparable in being a state-designated national institution for epidemiological surveillance, AMR strategy, and pandemic response coordination.
• Institut Pasteur: France's internationally recognized biomedical research institute with deep focus on infectious diseases, vaccinology, and epidemiology. Comparable as a national reference institution, though more research-focused than Matei Bals' clinical delivery emphasis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/inbi-matei-bals

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INBI Matei Bals